Champions Oncology Inc (CSBR)

[lumdus]

In the Israeli press, in Hebrew, it was announced that CSBR is creating a subsidiary with Guy Malchi at it's head. They are placing the one drug we have in development into the subsidiary and setting up the Company to look for additional drug candidates. They are going to raise an initial $3-$4 million dollars to fund their activities. This is all supposed to happen by the end of the year. The article said that CSBR will only own a minority stake in the new subsidiary after the raise.

CSBR needs to confirm (with a PR) or deny this information because it is material information for shareholders and potential investors.

I'd like to understand why CSBR can't create the subsidiary, raise the necessary funds, and still retain a majority stake in the Company. I'd like to know who the people are that are benefiting from the one drug we have and the drug development business model new management decided to discontinue.

I feel totally in the dark with this Company. I think it's time they worked on their shareholder relations.